Get access

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

  • Protocol
  • Intervention

Authors

  • C Lafuente-Lafuente,

  • S Mouly,

  • MA Longas-Tejero,

  • JF Bergmann


Dr Carmelo Lafuente-Lafuente, Praticien Attache, Service de Médecine Interne A, Hôpital Lariboisière, 2, rue ambroise Paré, Paris, 75010, FRANCE. c.lafuente@nodo3.net.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effect of long-term treatment with antiarrhythmic drugs in patients who have recovered sinus rhythm after having atrial fibrillation, to reduce death, stroke and embolism, drug adverse effects and recurrence of atrial fibrillation.

Primary aim is to assess the effects of any antiarrhythmic drugs compared with no antiarrhythmic drugs treatment, no treatment, placebo, or treatment for rate control. If several antiarrhythmic drugs appear to be effective the secondary aim will be to assess which is more effective.